Antioxidant properties of the cerebrospinal fluid in neurodegenerative diseases

被引:0
|
作者
Kolmakova, T. S. [1 ]
Smirnova, O. B. [1 ]
Belyakova, E. I. [1 ]
机构
[1] S Fed Univ, Pedag Inst, Rostov Na Donu, Russia
关键词
catalase; SOD; free radical oxidation; antioxidant system; cerebrospinal fluid; brain; experimental allergic encephalomyelitis;
D O I
10.1134/S1819712410010083
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cerebrospinal fluid contains elements of the antioxidant system that are involved in the maintenance of homeostasis of the nervous tissue and its protection from free radical damage. Functional imbalances between antioxidant enzymes of the cerebrospinal fluid, such as superoxide dismutase (SOD) and catalase, have been revealed in schizophrenia, epilepsy, and multiple sclerosis. In neurological diseases SOD activity was higher, while catalase activity was lower as compared to the group of patients suffering from osteochondrosis, which was used for comparison. A decrease in the antioxidant capacity of the cerebrospinal fluid is associated with the accumulation of substances that induce oxidative stress in the brain. Incubation of patients' cerebrospinal fluid with homogenates of rat brain structures resulted in the activation of free radical processes. In canines, the development of experimental allergic encephalomyelitis (EAE) was accompanied by a decrease in the activity of enzymes of antioxidant (AO) defense as compared to intact animals. In animals that did not become ill the enzymatic activity was similar to the control. We hypothesized that the antioxidant system of the cerebrospinal fluid regulates the oxidative homeostasis of the brain. Inhibition of this system is one of the causes of oxidative stress in degenerative diseases of the nervous system.
引用
收藏
页码:41 / 45
页数:5
相关论文
共 50 条
  • [1] Antioxidant properties of the cerebrospinal fluid in neurodegenerative diseases
    T. S. Kolmakova
    O. B. Smirnova
    E. I. Belyakova
    Neurochemical Journal, 2010, 4 : 41 - 45
  • [2] Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases
    Brettschneider, Johannes
    Widl, Karin
    Ehrenreich, Hannelore
    Riepe, Matthias
    Tumani, Hayrettin
    NEUROSCIENCE LETTERS, 2006, 404 (03) : 347 - 351
  • [3] Cerebrospinal Fluid and Plasma Biomarkers in Neurodegenerative Diseases
    Seino, Yusuke
    Nakamura, Takumi
    Kawarabayashi, Takeshi
    Hirohata, Mie
    Narita, Sakiko
    Wakasaya, Yasuhito
    Kaito, Kozue
    Ueda, Tetsuya
    Harigaya, Yasuo
    Shoji, Mikio
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (01) : 395 - 404
  • [4] Neuropathological Validation of Cerebrospinal Fluid Biomarkers in Neurodegenerative Diseases
    Irwin, David J.
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2020, 5 (01): : 232 - 238
  • [5] Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
    Jesse, Sarah
    Brettschneider, Johannes
    Suessmuth, Sigurd D.
    Landwehrmeyer, Bernhard G.
    von Arnim, Christine A. F.
    Ludolph, Albert C.
    Tumani, Hayrettin
    Otto, Markus
    JOURNAL OF NEUROLOGY, 2011, 258 (06) : 1034 - 1041
  • [6] Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
    Sarah Jesse
    Johannes Brettschneider
    Sigurd D. Süssmuth
    Bernhard G. Landwehrmeyer
    Christine A. F. von Arnim
    Albert C. Ludolph
    Hayrettin Tumani
    Markus Otto
    Journal of Neurology, 2011, 258 : 1034 - 1041
  • [7] Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases
    Otto, Markus
    Lewczuk, Piotr
    Wiltfang, Jens
    METHODS, 2008, 44 (04) : 289 - 298
  • [8] The Diagnostic Value of Cerebrospinal Fluid Neurogranin in Neurodegenerative Diseases
    Krawczuk, Daria
    Mroczko, Piotr
    Winkel, Izabela
    Mroczko, Barbara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (24)
  • [9] Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases
    Zhang, Jing
    Goodlett, David R.
    Montine, Thomas J.
    JOURNAL OF ALZHEIMERS DISEASE, 2005, 8 (04) : 377 - 386
  • [10] Metabolites and Biomarker Compounds of Neurodegenerative Diseases in Cerebrospinal Fluid
    Wakamatsu, Keiji
    Chiba, Yoichi
    Murakami, Ryuta
    Miyai, Yumi
    Matsumoto, Koichi
    Kamada, Masaki
    Nonaka, Wakako
    Uemura, Naoya
    Yanase, Ken
    Ueno, Masaki
    METABOLITES, 2022, 12 (04)